Filed: 5/15/2024ACC: 0001420506-24-000902
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 68 equity positions with a total reported market value of $361.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
68
Positions
$361.29M
Total AUM (reported)
25.79M
Total Shares
Allocation by class
COM$272.75M75.5%
S&P BIOTECH$23.72M6.6%
COM NEW$20.84M5.8%
CLASS A ORD$15.07M4.2%
SHS$14.56M4.0%
COM PAR $.01$4.07M1.1%
SPONSORED ADS$3.21M0.9%
Portfolio Concentration
Top 3$56.66M15.7%
4–10$91.30M25.3%
11–25$110.31M30.5%
Rest$103.02M28.5%
Top 3 weight
15.7%
Top 10 weight
41.0%
Voting Authority Distribution
Total shares with voting rights: 25.79M
Sole
Full voting authority
25.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole68
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings68
Rows:
SPDR SER TR
SOLEShares250K
TypeSH
Market value$23.72M
6.57%
Sole
250K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares210K
TypeSH
Market value$16.76M
4.64%
Sole
210K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$16.18M
4.48%
Sole
125K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares285K
TypeSH
Market value$15.59M
4.31%
Sole
285K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares300K
TypeSH
Market value$15.07M
4.17%
Sole
300K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.30M
TypeSH
Market value$13.70M
3.79%
Sole
1.30M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares825K
TypeSH
Market value$12.55M
3.47%
Sole
825K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares153K
TypeSH
Market value$12.55M
3.47%
Sole
153K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares625K
TypeSH
Market value$10.94M
3.03%
Sole
625K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares300K
TypeSH
Market value$10.90M
3.02%
Sole
300K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares200K
TypeSH
Market value$9.36M
2.59%
Sole
200K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares60K
TypeSH
Market value$8.97M
2.48%
Sole
60K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares275K
TypeSH
Market value$8.89M
2.46%
Sole
275K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$8.56M
2.37%
Sole
200K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.60M
TypeSH
Market value$7.97M
2.21%
Sole
1.60M
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares425K
TypeSH
Market value$7.86M
2.18%
Sole
425K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares130K
TypeSH
Market value$7.64M
2.12%
Sole
130K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares6M
TypeSH
Market value$7.14M
1.98%
Sole
6M
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares72.76K
TypeSH
Market value$6.90M
1.91%
Sole
72.76K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares95K
TypeSH
Market value$6.66M
1.84%
Sole
95K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares225K
TypeSH
Market value$6.65M
1.84%
Sole
225K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares95K
TypeSH
Market value$6.49M
1.80%
Sole
95K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares375K
TypeSH
Market value$6.40M
1.77%
Sole
375K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares125K
TypeSH
Market value$5.42M
1.50%
Sole
125K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares175K
TypeSH
Market value$5.41M
1.50%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 250K | SH | $23.72M 6.57% | 250K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 210K | SH | $16.76M 4.64% | 210K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 125K | SH | $16.18M 4.48% | 125K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 285K | SH | $15.59M 4.31% | 285K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 300K | SH | $15.07M 4.17% | 300K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1.30M | SH | $13.70M 3.79% | 1.30M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 825K | SH | $12.55M 3.47% | 825K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 153K | SH | $12.55M 3.47% | 153K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 625K | SH | $10.94M 3.03% | 625K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 300K | SH | $10.90M 3.02% | 300K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 200K | SH | $9.36M 2.59% | 200K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 60K | SH | $8.97M 2.48% | 60K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 275K | SH | $8.89M 2.46% | 275K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 200K | SH | $8.56M 2.37% | 200K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.60M | SH | $7.97M 2.21% | 1.60M | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 425K | SH | $7.86M 2.18% | 425K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 130K | SH | $7.64M 2.12% | 130K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM | 6M | SH | $7.14M 1.98% | 6M | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 72.76K | SH | $6.90M 1.91% | 72.76K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 95K | SH | $6.66M 1.84% | 95K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 225K | SH | $6.65M 1.84% | 225K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 95K | SH | $6.49M 1.80% | 95K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 375K | SH | $6.40M 1.77% | 375K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 125K | SH | $5.42M 1.50% | 125K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 175K | SH | $5.41M 1.50% | 175K | 0.00 | 0.00 |
Page 1 of 3